8-K: Ascend Wellness Holdings Reports Full Year 2024 Revenue Up 8% to $562 Million, Adjusted EBITDA Increases 9%
Earnings Release
Ascend Wellness Holdings (AWH) announces its fourth quarter and full year 2024 financial results, highlighting revenue growth, improved profitability, and positive cash flow.
Summary
- Ascend Wellness Holdings (AWH) reported an 8% increase in full year 2024 net revenue, reaching $562 million.
- Adjusted EBITDA for the full year increased by 9% to $116 million.
- The company achieved its second full year of positive cash from operations and positive free cash flow.
- AWH ended Q4 2024 with $88 million in cash and cash equivalents.
- The company's cost savings transformation initiatives positively impacted Adjusted EBITDA, reaching $30.2 million, and Adjusted Gross Margin, reaching 41.9% in Q4.
- Vertical sales increased by 6% sequentially, driven by demand for AWH's in-house brands.
- AWH generated $30.1 million in Free Cash Flow in Q4.
- The company plans to increase its store count by 50% in the medium term through its densification strategy.
- AWH launched Effin, an effect-based brand, which quickly became the top-selling edibles category at Ascend stores where it is available.
- The company repurchased 11 million shares of Class A common stock and announced a share buyback program.
- Four dispensaries were opened during 2024, and adult-use sales commenced at five dispensaries in Ohio, resulting in a sales increase of over three times compared to prior performance.
- Wholesale revenue increased in each of the company's key markets, with over 187,000 pounds of wholesale products sold.
- AWH aims to streamline operations and reduce expenditures by $30 million on an annualized basis.
- Net loss for FY 2024 was $85.0 million, compared to a net loss of $48.2 million for FY 2023.
- Adjusted EBITDA Margin for FY 2024 was 20.7%, a 15-basis point increase compared to the prior year.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While the company shows revenue and EBITDA growth, the increased net loss and quarter-over-quarter revenue declines temper the overall outlook. The cost-saving initiatives and strategic moves like share buybacks are positive signals, but the financial challenges cannot be ignored.
Positives
- Revenue increased by 8% year-over-year to $562 million.
- Adjusted EBITDA increased by 9% year-over-year to $116 million.
- The company has positive cash from operations and positive free cash flow.
- AWH has $88 million in cash and cash equivalents.
- Cost savings initiatives have positively impacted Adjusted EBITDA and Adjusted Gross Margin.
- Vertical sales increased by 6% sequentially.
- The company is implementing a densification strategy to increase store count.
- AWH successfully repurchased 11 million shares of Class A common stock.
- Wholesale revenue increased 28.5% year-over-year to $189.4 million.
- The company is focused on continuous improvement and has identified additional cost savings and efficiency opportunities that it plans to implement over the course of 2025.
Negatives
- Net loss for 2024 was $85.0 million, compared to a net loss of $48.2 million for 2023.
- Total net revenue declined 4.0% quarter-over-quarter to $136.0 million.
- Retail revenue decreased 3.5% quarter-over-quarter to $90.4 million.
- Wholesale revenue decreased 5.0% quarter-over-quarter to $45.6 million.
- Adjusted Gross Profit margin decreased 8-basis points year-over-year driven by margin declines in Illinois and Massachusetts cultivation and Michigan retail.
Risks
- Increased competition and pricing pressure in New Jersey, Illinois, and Massachusetts led to a decline in retail sales.
- Declines in Michigan retail sales were mainly driven by pricing pressure.
- The company's forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially.
- The preliminary financial metrics are subject to change upon completion of the audit.
Future Outlook
The company is focused on executing its densification strategy, driving revenue growth, and implementing additional cost savings and efficiency opportunities in 2025.
Management Comments
- Sam Brill, Chief Executive Officer: 'The fourth quarter marked the first full quarter with our new management team in place, and I am pleased with the initial progress we made on our key initiatives – improving profitability, maximizing asset efficiency, and driving cash flow generation.'
- Frank Perullo, Co-Founder and President: 'We are building our business for long-term success and are focused on providing patients and consumers with consistent, high-quality products in an approachable and elevated retail experience.'
- Roman Nemchenko, Chief Financial Officer: 'Significant progress has been made in strengthening our balance sheet and improving our margins and profitability.'
Industry Context
AWH's focus on cost savings, densification strategy, and brand recognition aligns with the broader industry trend of cannabis companies seeking sustainable profitability and market share in an increasingly competitive landscape. The expansion into adult-use sales in Ohio is also a key development, reflecting the growing acceptance and legalization of cannabis across states.
Comparison to Industry Standards
- Comparing AWH's 8% revenue growth to peers like Curaleaf and Green Thumb Industries, which have also reported revenue growth, AWH's performance is within a similar range, indicating a competitive position in the market.
- AWH's Adjusted EBITDA margin of 20.7% is comparable to other multi-state operators (MSOs) such as Trulieve, which have demonstrated similar profitability levels.
- The company's focus on cost savings and efficiency improvements mirrors the strategies employed by other cannabis companies to navigate pricing pressures and maintain profitability.
- The densification strategy, aiming for a 50% increase in store count, is an aggressive expansion plan, similar to strategies employed by companies like Cresco Labs in key markets.
Stakeholder Impact
- Shareholders may benefit from the share buyback program and potential long-term growth.
- Employees may be affected by cost-saving initiatives and headcount reductions.
- Customers can expect consistent, high-quality products and an elevated retail experience.
- Suppliers may see increased wholesale revenue in key markets.
- Creditors should be reassured by the company's positive cash flow and efforts to strengthen its balance sheet.
Next Steps
- Execute densification strategy to increase store count.
- Implement additional cost savings and efficiency opportunities.
- Focus on driving revenue growth.
- Continue to improve balance sheet and margins.
Key Dates
| Date | Description |
|---|---|
| December 17, 2024 | Date referenced for the closing price on the Canadian Securities Exchange (CSE) related to the share repurchase. |
| December 31, 2024 | End of the fourth quarter and full year for which financial results are reported. |
| January 2025 | Start of the share buyback program. |
| February 2025 | Re-opening of the Detroit, Michigan dispensary after expansion for adult-use sales. |
| March 12, 2025 | Date of the press release and conference call to discuss financial results. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.